This inventor holds 37 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Compositions. Top assignees: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., Richter Gedeon Vegyeszeti Gyar Rt, Basf Aktiengesellschaft. Active years: 1976-1995.
Company Filing History:
24 out of 283 
3 out of 346 
2 out of 10,754 
Years Active: 1976-1995
Areas of Expertise:
Title: Innovations of Jozsef Knoll: A Pharmaceutical Pioneer
Introduction
Jozsef Knoll is a notable inventor based in Budapest, Hungary, with an impressive portfolio of 37 patents. His work primarily focuses on the development of pharmaceutical compositions and compounds, showcasing his significant contributions to the field of medicinal chemistry.
Latest Patents
Among his latest innovations are the novel compounds titled "3-(substituted tetrazolyl)-4-oxo-4H-pyrido-[1,2-a]pyrimidines" and "Pyridopyrimidine derivatives." These patents detail pharmaceutical compositions involving unique 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxamide derivatives. Specifically, the general formula (I) pertains to compounds where R represents a C1-12 alkyl group, which may be optionally substituted by a C1-4 alkoxycarbonyl group, a C3-9 cycloalkyl, adamantyl, or an optionally substituted phenyl group. This innovative work underlines his commitment to advancing pharmaceutical science.
Career Highlights
Jozsef Knoll's career is marked by his tenure at leading pharmaceutical companies, notably Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. and Richter Gedeon Vegyeszeti Gyar Rt. His experiences in these organizations have allowed him to refine his skills and enhance his contributions to drug development and research.
Collaborations
Throughout his career, Knoll collaborated with esteemed colleagues such as Istvan Hermecz and Zoltan Meszaros. These partnerships have facilitated a rich exchange of ideas and knowledge, further driving innovation in their respective fields.
Conclusion
In summary, Jozsef Knoll's extensive patent portfolio and collaborative efforts underscore his role as a pioneer in medicinal chemistry. His innovative contributions continue to impact the pharmaceutical industry, paving the way for new therapeutic options that benefit society.